BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22312813)

  • 1. [Causes of patients' non-adherence with glaucoma medication dosing: systemic classification based on dosing schedule].
    Kobayashi H
    Nippon Ganka Gakkai Zasshi; 2011 Dec; 115(12):1086-93. PubMed ID: 22312813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Change in the Causes Precluding Adherence of Glaucoma Medication Regimen: Systemic Analysis over 12 Months].
    Kobayashi H
    Nippon Ganka Gakkai Zasshi; 2016 Oct; 120(10):673-81. PubMed ID: 30088399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.
    Ford BA; Gooi M; Carlsson A; Crichton AC
    J Glaucoma; 2013 Jan; 22(1):1-4. PubMed ID: 21946541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical investigation of medication adherence of glaucoma patients].
    Wu HY; Yin JF
    Zhonghua Yan Ke Za Zhi; 2010 Jun; 46(6):494-8. PubMed ID: 21055192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance barriers in glaucoma: a systematic classification.
    Tsai JC; McClure CA; Ramos SE; Schlundt DG; Pichert JW
    J Glaucoma; 2003 Oct; 12(5):393-8. PubMed ID: 14520147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance in patients prescribed eyedrops for glaucoma.
    Patel SC; Spaeth GL
    Ophthalmic Surg; 1995; 26(3):233-6. PubMed ID: 7651690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of the Travalert(®) dosing aid on medical treatment compliance and the quality of life of glaucoma patients].
    Sánchez-Pulgarín M; Martínez-de-la-Casa JM; Escalada A; Sáenz-Francés F; García-Feijoó J; García Sánchez J
    Arch Soc Esp Oftalmol; 2011 Sep; 86(9):282-6. PubMed ID: 21893261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of written instructions on accuracy of self-reporting medication regimen in glaucoma patients.
    Kharod BV; Johnson PB; Nesti HA; Rhee DJ
    J Glaucoma; 2006 Jun; 15(3):244-7. PubMed ID: 16778648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study of compliance and drop administration in glaucoma.
    Kholdebarin R; Campbell RJ; Jin YP; Buys YM
    Can J Ophthalmol; 2008 Aug; 43(4):454-61. PubMed ID: 18711461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
    Robin AL; Novack GD; Covert DW; Crockett RS; Marcic TS
    Am J Ophthalmol; 2007 Oct; 144(4):533-40. PubMed ID: 17686450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).
    Vandenbroeck S; De Geest S; Dobbels F; Fieuws S; Stalmans I; Zeyen T
    J Glaucoma; 2011 Sep; 20(7):414-21. PubMed ID: 21048510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore.
    Loon SC; Jin J; Jin Goh M
    J Glaucoma; 2015; 24(5):e36-42. PubMed ID: 24248002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice.
    Friedman DS; Hahn SR; Quigley HA; Kotak S; Kim E; Onofrey M; Eagan C; Mardekian J
    Ophthalmology; 2009 Dec; 116(12):2277-85.e1-3. PubMed ID: 19744715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugs.
    Martin-Latry K; Cazaux J; Lafitte M; Couffinhal T
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1088-92. PubMed ID: 24648258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.